Moderna
Bookmark
ShareModerna is a company. It is in Cambridge, the United States and it has a male CEO called Stephane Bancel. It was founded in 2010 and is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Cambridge
- environmental score (ESG): Try Pro to see estimate
- ESG score: Try Pro to see estimate
- CEO approval: 77 %
- CEO gender: male
- CEO: Stephane Bancel
- foundation year: 2010
- industry: Biotechnology
- sector: Health Care
- revenues: 22.6B $
- employees: 3,200 people
- country: United States
- state: MA
- social score (ESG): Try Pro to see estimate
- governance score (ESG): Try Pro to see estimate
See more facts
Extract data
Download datasets about Moderna:
Dataset of stocks from Moderna:
Moderna is one of the companies in the United States, companies in Biotechnology, companies in Health Care, companies in Stephane Bancel, companies in Cambridge and 3,584,319 companies in our database.
Talking Points
- Pioneering mRNA technologyModerna Canada
- Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.
- Our mission is to deliver the greatest possible impact to people through mRNA medicines.
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
